L PERRIGO CO FDA Approval ANDA 216096

ANDA 216096

L PERRIGO CO

FDA Drug Application

Application #216096

Application Sponsors

ANDA 216096L PERRIGO CO

Marketing Status

Over-the-counter001

Application Products

001CAPSULE, DELAYED RELEASE;ORALEQ 20MG BASE0OMEPRAZOLE MAGNESIUMOMEPRAZOLE MAGNESIUM

FDA Submissions

UNKNOWN; ORIG1AP2022-05-24STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

L PERRIGO CO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216096
            [companyName] => L PERRIGO CO
            [docInserts] => ["",""]
            [products] => [{"drugName":"OMEPRAZOLE MAGNESIUM","activeIngredients":"OMEPRAZOLE MAGNESIUM","strength":"EQ 20MG BASE","dosageForm":"CAPSULE, DELAYED RELEASE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/24\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-05-24
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.